Wolde Facha
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Wolde Facha has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
Takele Tadesse
Department of Epidemiology and Biostatistics, School of Public Health, College of Health Sciences and Medicine, Wolaita Sodo University, Wolaita Sodo, Ethiopia
5 shared publicationsEskinder Wolka
Department of Epidemiology and Biostatistics, School of Public Health, College of Health Sciences and Medicine, Wolaita Sodo University, Wolaita Sodo, Ethiopia
4 shared publicationsAyalew Astatkie
School of Public Health, College of Medicine and Health Sciences, Hawassa University, Hawassa, Ethiopia
3 shared publications- Ayalew Astatkie
School of Public Health, College of Medicine and Health Sciences, Hawassa University, Hawassa, Ethiopia
3 shared publications - Teshale Fikadu
School of Public Health, College of Health Sciences and Medicine, Wolaita Sodo University, Wolaita Sodo, Ethiopia
3 shared publications Abera Beyamo
School of Public Health, College of Health Sciences and Medicine, WolaitaSodo University, WolaitaSodo, Ethiopia
2 shared publications
Latest Publications
- Open Access
- 13 September 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14  (1) , 1-9
A qualitative study on reasons for women’s loss and resumption of Option B plus care in Ethiopia
Loss to follow-up (LTFU) from Option B plus, a lifelong antiretroviral therapy (ART) for pregnant women living with human immunodeficiency virus (HIV), irrespective of their clinical stage and CD4 count, threatens the elimination of vertical transmission of the virus from mothers to their infants. However, evidence on reasons for LTFU and resumption after LTFU to Option B plus care among women has been limited in Ethiopia. Therefore, this study explored why women were LTFU from the service and what made them resume or refuse resumption after LTFU in Ethiopia. An exploratory, descriptive qualitative study using 46 in-depth interviews was employed among purposely selected women who were lost from Option B plus care or resumed care after LTFU, health care providers, and mother support group (MSG) members working in the prevention of mother-to-child transmission unit. A thematic analysis using an inductive approach was used to analyze the data and build subthemes and themes. Open Code Version 4.03 software assists in data management, from open coding to developing themes and sub-themes. We found that low socioeconomic status, poor relationship with husband and/or family, lack of support from partners, family members, or government, HIV-related stigma, and discrimination, lack of awareness on HIV treatment and perceived drug side effects, religious belief, shortage of drug supply, inadequate service access, and fear of confidentiality breach by healthcare workers were major reasons for LTFU. Healthcare workers' dedication to tracing lost women, partner encouragement, and feeling sick prompted women to resume care after LTFU. This study highlighted financial burdens, partner violence, and societal and health service-related factors discouraged compliance to retention among women in Option B plus care in Ethiopia. Women's empowerment and partner engagement were of vital importance to retain them in care and eliminate vertical transmission of the virus among infants born to HIV-positive women.
- 13 September 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14  (1) , 1-9
Open AccessA qualitative study on reasons for women’s loss and resumption of Option B plus care in Ethiopia
Loss to follow-up (LTFU) from Option B plus, a lifelong antiretroviral therapy (ART) for pregnant women living with human immunodeficiency virus (HIV), irrespective of their clinical stage and CD4 count, threatens the elimination of vertical transmission of the virus from mothers to their infants. However, evidence on reasons for LTFU and resumption after LTFU to Option B plus care among women has been limited in Ethiopia. Therefore, this study explored why women were LTFU from the service and what made them resume or refuse resumption after LTFU in Ethiopia. An exploratory, descriptive qualitative study using 46 in-depth interviews was employed among purposely selected women who were lost from Option B plus care or resumed care after LTFU, health care providers, and mother support group (MSG) members working in the prevention of mother-to-child transmission unit. A thematic analysis using an inductive approach was used to analyze the data and build subthemes and themes. Open Code Version 4.03 software assists in data management, from open coding to developing themes and sub-themes. We found that low socioeconomic status, poor relationship with husband and/or family, lack of support from partners, family members, or government, HIV-related stigma, and discrimination, lack of awareness on HIV treatment and perceived drug side effects, religious belief, shortage of drug supply, inadequate service access, and fear of confidentiality breach by healthcare workers were major reasons for LTFU. Healthcare workers' dedication to tracing lost women, partner encouragement, and feeling sick prompted women to resume care after LTFU. This study highlighted financial burdens, partner violence, and societal and health service-related factors discouraged compliance to retention among women in Option B plus care in Ethiopia. Women's empowerment and partner engagement were of vital importance to retain them in care and eliminate vertical transmission of the virus among infants born to HIV-positive women.
- Open Access
- 2 July 2024
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 12, 1385441
Attrition from care and its predictors among women exposed to dolutegravir- and efavirenz-based first-line antiretroviral therapy in Ethiopia: a before-and-after study
Background: The effect of dolutegravir (DTG)-based regimens on reducing attrition from care among women enrolled in the prevention of mother-to-child transmission (PMTCT) care program is unknown. Therefore, this study aimed to compare the incidence of attrition among women exposed to DTG-based with those exposed to efavirenz (EFV)-based first-line antiretroviral therapy (ART) in Ethiopia.Methods: An uncontrolled before-and-after study was conducted involving 932 women (with 466 on EFV-based and 466 on DTG-based regimens) who were enrolled in the PMTCT care program from September 2015 to February 2023. The outcome variable was attrition (i.e., maternal death or loss to follow-up before their infants' final HIV status was determined). A Kaplan–Meier estimator was employed to estimate the probability of attrition. The Cox proportional hazards regression model was fitted to identify predictor variables. The adjusted hazard ratio (aHR) with the corresponding 95% confidence interval (CI) was calculated to examine the risk difference in the comparison groups.Results: The cumulative incidence of attrition among women was 5.2% (3.0% for those placed in the DTG-based regimen arm and 7.3% for those placed in the EFV-based regimen arm). Women on DTG-based regimens had a 57% (aHR: 0.43; 95% CI: 0.23–0.80) lower risk of attrition from care compared to those on EFV-based regimens. Women who delivered their infants at home (aHR: 2.35; 95% CI: 1.14–4.85), had poor/fair adherence (aHR: 3.23; 95% CI: 1.62–6.45), had unsuppressed/unknown viral load status (aHR: 2.61; 95% CI: 1.42–4.79), and did not disclose their status to partners (aHR: 2.56; 95% CI: 1.34–4.92) had a higher risk of attrition from PMTCT care compared to their counterparts.Conclusion: The cumulative incidence of attrition among women receiving PMTCT care is optimal. In addition, the risk of attrition among women receiving DTG-based regimens is lower than that among women receiving EFV-based regimens. Thus, DTG-based first-line ART regimen supplementation should be sustained to achieve a national retention target of 95% and above.
- 2 July 2024
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 12, 1385441
Open AccessAttrition from care and its predictors among women exposed to dolutegravir- and efavirenz-based first-line antiretroviral therapy in Ethiopia: a before-and-after study
Background: The effect of dolutegravir (DTG)-based regimens on reducing attrition from care among women enrolled in the prevention of mother-to-child transmission (PMTCT) care program is unknown. Therefore, this study aimed to compare the incidence of attrition among women exposed to DTG-based with those exposed to efavirenz (EFV)-based first-line antiretroviral therapy (ART) in Ethiopia.Methods: An uncontrolled before-and-after study was conducted involving 932 women (with 466 on EFV-based and 466 on DTG-based regimens) who were enrolled in the PMTCT care program from September 2015 to February 2023. The outcome variable was attrition (i.e., maternal death or loss to follow-up before their infants' final HIV status was determined). A Kaplan–Meier estimator was employed to estimate the probability of attrition. The Cox proportional hazards regression model was fitted to identify predictor variables. The adjusted hazard ratio (aHR) with the corresponding 95% confidence interval (CI) was calculated to examine the risk difference in the comparison groups.Results: The cumulative incidence of attrition among women was 5.2% (3.0% for those placed in the DTG-based regimen arm and 7.3% for those placed in the EFV-based regimen arm). Women on DTG-based regimens had a 57% (aHR: 0.43; 95% CI: 0.23–0.80) lower risk of attrition from care compared to those on EFV-based regimens. Women who delivered their infants at home (aHR: 2.35; 95% CI: 1.14–4.85), had poor/fair adherence (aHR: 3.23; 95% CI: 1.62–6.45), had unsuppressed/unknown viral load status (aHR: 2.61; 95% CI: 1.42–4.79), and did not disclose their status to partners (aHR: 2.56; 95% CI: 1.34–4.92) had a higher risk of attrition from PMTCT care compared to their counterparts.Conclusion: The cumulative incidence of attrition among women receiving PMTCT care is optimal. In addition, the risk of attrition among women receiving DTG-based regimens is lower than that among women receiving EFV-based regimens. Thus, DTG-based first-line ART regimen supplementation should be sustained to achieve a national retention target of 95% and above.
- Open Access
- 10 June 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19  (6) , e0305331
Viral load non-suppression status among women exposed to Dolutegravir-based versus Efavirenz-based regimens in Ethiopia: A before-and-after study
Background: High viral load during pregnancy and breastfeeding period is the risk factor for vertical transmission of human immunodeficiency virus (HIV). Currently, Dolutegravir (DTG)-based regimens are recommended to attain adequate viral load suppression (VLS) among women. However, its effect on VLS has not been investigated among women in PMTCT care in Ethiopia. Objective: This study aimed to investigate the rate of viral load non-suppression among women exposed to DTG-based versus Efavirenz (EFV)-based regimens in Ethiopia. Methods: An uncontrolled before-and-after study design was conducted among 924 women (462 on EFV-based and 462 on DTG-based regimens) enrolled in PMTCT care from September 2015 to February 2023. The outcome variable was the viral load (VL) non-suppression among women on PMTCT care. A modified Poisson regression model was employed, and the proportion was computed to compare the rate of VL non-suppression in both groups. The risk ratio (RR) with a 95% confidence interval (CI) was calculated to assess viral load non-suppression among women on DTG-based and EFV-based regimens by adjusting for other variables. Results: The overall rate of non-suppressed VL was 16.2% (95% CI: 14.0–18.8%). Mothers on DTG-based regimens had approximately a 30% (adjusted risk ratio (aRR): 0.70; 95% CI: 0.52–0.94) lesser risk of developing non-suppressed VL than women on EFV-based regimens. Besides, older women were 1.38 times (aRR: 1.38; 95% CI: 1.04–1.83); mothers who did not disclose their HIV status to their partners were 2.54 times (aRR: 2.54; 95% CI: 1.91–3.38); and mothers who had poor or fair adherence to antiretroviral (ARV) drugs were 2.11 times (aRR: 2.11; 95% CI: 1.45–3.07) at higher risk of non-suppressed VL. Conclusion: Women on DTG-based regimens had a significantly suppressed VL compared to those on EFV-based regimens. Thus, administering DTG-based first-line ART regimens should be strengthened to achieve global and national targets on VLS.
- 10 June 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19  (6) , e0305331
Open AccessViral load non-suppression status among women exposed to Dolutegravir-based versus Efavirenz-based regimens in Ethiopia: A before-and-after study
Background: High viral load during pregnancy and breastfeeding period is the risk factor for vertical transmission of human immunodeficiency virus (HIV). Currently, Dolutegravir (DTG)-based regimens are recommended to attain adequate viral load suppression (VLS) among women. However, its effect on VLS has not been investigated among women in PMTCT care in Ethiopia. Objective: This study aimed to investigate the rate of viral load non-suppression among women exposed to DTG-based versus Efavirenz (EFV)-based regimens in Ethiopia. Methods: An uncontrolled before-and-after study design was conducted among 924 women (462 on EFV-based and 462 on DTG-based regimens) enrolled in PMTCT care from September 2015 to February 2023. The outcome variable was the viral load (VL) non-suppression among women on PMTCT care. A modified Poisson regression model was employed, and the proportion was computed to compare the rate of VL non-suppression in both groups. The risk ratio (RR) with a 95% confidence interval (CI) was calculated to assess viral load non-suppression among women on DTG-based and EFV-based regimens by adjusting for other variables. Results: The overall rate of non-suppressed VL was 16.2% (95% CI: 14.0–18.8%). Mothers on DTG-based regimens had approximately a 30% (adjusted risk ratio (aRR): 0.70; 95% CI: 0.52–0.94) lesser risk of developing non-suppressed VL than women on EFV-based regimens. Besides, older women were 1.38 times (aRR: 1.38; 95% CI: 1.04–1.83); mothers who did not disclose their HIV status to their partners were 2.54 times (aRR: 2.54; 95% CI: 1.91–3.38); and mothers who had poor or fair adherence to antiretroviral (ARV) drugs were 2.11 times (aRR: 2.11; 95% CI: 1.45–3.07) at higher risk of non-suppressed VL. Conclusion: Women on DTG-based regimens had a significantly suppressed VL compared to those on EFV-based regimens. Thus, administering DTG-based first-line ART regimens should be strengthened to achieve global and national targets on VLS.
- Open Access
- 7 June 2024
- Published by Springer Nature in AIDS Research and Therapy
- Vol. 21  (1) , 1-12
Magnitude and risk factors of mother-to-child transmission of HIV among HIV-exposed infants after Option B+ implementation in Ethiopia: a systematic review and meta-analysis
Background: Mother-to-child transmission (MTCT) of the human immunodeficiency virus (HIV) remains a major public health challenge in Ethiopia. The objective of this review was to assess the pooled magnitude of MTCT of HIV and its risk factors among mother-infant pairs who initiated antiretroviral therapy (ART) after Option B+ in Ethiopia. Methods: A systematic search of literature from PubMed, Hinari, African Journals Online (AJOL), Science Direct, and Google Scholar databases was conducted from June 11, 2013 to August 1, 2023. The authors used the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines to guide the article selection process and reporting. Observational studies that reported the magnitude and/or risk factors on MTCT of HIV among mother-infant pairs who initiated ART after the implementation of Option B+ in Ethiopia were included. We applied a random-effect model meta-analysis to estimate the overall pooled magnitude and risk factors of MTCT of HIV. A funnel plot and Egger’s regression test were employed to check publication bias, and heterogeneity was assessed using I2 statistics. The protocol was registered in the PROSPERO database with registration ID number CRD42022325938. Result: Eighteen published articles on the magnitude of MTCT and 16 published articles on its risk factors were included in this review. The pooled magnitude of MTCT of HIV after the Option B+ program in Ethiopia was 4.05% (95% CI 3.09, 5.01). Mothers who delivered their infants at home [OR: 9.74; (95% CI: 6.89–13.77)], had not been on ART intervention [OR: 19.39; (95% CI: 3.91–96.18)], had poor adherence to ART [OR: 7.47; (95% CI: 3.40–16.45)], initiated ART during pregnancy [OR: 5.09; (95% CI: 1.73–14.97)], had WHO clinical stage 2 and above [OR: 4.95; (95% CI: 1.65–14.88]], had a CD4 count below 350 at enrolment [OR: 5.78; (95% CI: 1.97–16.98], had no or low male partner involvement [OR: 5.92; (95% CI: 3.61–9.71]] and whose partner was not on ART [OR: 8.08; (95% CI: 3.27–19.93]] had higher odds of transmitting HIV to their infants than their counterparts. Conclusion: This review showed that the pooled magnitude of MTCT of HIV among mother-infant pairs who initiated ART after the Option B + program in Ethiopia is at the desired target of the WHO, which is less than 5% in breastfeeding women. Home delivery, lack of male partner involvement, advanced HIV-related disease, lack of PMTCT intervention, and poor ARV adherence were significant risk factors for MTCT of HIV in Ethiopia.
- 7 June 2024
- Published by Springer Nature in AIDS Research and Therapy
- Vol. 21  (1) , 1-12
Open AccessMagnitude and risk factors of mother-to-child transmission of HIV among HIV-exposed infants after Option B+ implementation in Ethiopia: a systematic review and meta-analysis
Background: Mother-to-child transmission (MTCT) of the human immunodeficiency virus (HIV) remains a major public health challenge in Ethiopia. The objective of this review was to assess the pooled magnitude of MTCT of HIV and its risk factors among mother-infant pairs who initiated antiretroviral therapy (ART) after Option B+ in Ethiopia. Methods: A systematic search of literature from PubMed, Hinari, African Journals Online (AJOL), Science Direct, and Google Scholar databases was conducted from June 11, 2013 to August 1, 2023. The authors used the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines to guide the article selection process and reporting. Observational studies that reported the magnitude and/or risk factors on MTCT of HIV among mother-infant pairs who initiated ART after the implementation of Option B+ in Ethiopia were included. We applied a random-effect model meta-analysis to estimate the overall pooled magnitude and risk factors of MTCT of HIV. A funnel plot and Egger’s regression test were employed to check publication bias, and heterogeneity was assessed using I2 statistics. The protocol was registered in the PROSPERO database with registration ID number CRD42022325938. Result: Eighteen published articles on the magnitude of MTCT and 16 published articles on its risk factors were included in this review. The pooled magnitude of MTCT of HIV after the Option B+ program in Ethiopia was 4.05% (95% CI 3.09, 5.01). Mothers who delivered their infants at home [OR: 9.74; (95% CI: 6.89–13.77)], had not been on ART intervention [OR: 19.39; (95% CI: 3.91–96.18)], had poor adherence to ART [OR: 7.47; (95% CI: 3.40–16.45)], initiated ART during pregnancy [OR: 5.09; (95% CI: 1.73–14.97)], had WHO clinical stage 2 and above [OR: 4.95; (95% CI: 1.65–14.88]], had a CD4 count below 350 at enrolment [OR: 5.78; (95% CI: 1.97–16.98], had no or low male partner involvement [OR: 5.92; (95% CI: 3.61–9.71]] and whose partner was not on ART [OR: 8.08; (95% CI: 3.27–19.93]] had higher odds of transmitting HIV to their infants than their counterparts. Conclusion: This review showed that the pooled magnitude of MTCT of HIV among mother-infant pairs who initiated ART after the Option B + program in Ethiopia is at the desired target of the WHO, which is less than 5% in breastfeeding women. Home delivery, lack of male partner involvement, advanced HIV-related disease, lack of PMTCT intervention, and poor ARV adherence were significant risk factors for MTCT of HIV in Ethiopia.
- Open Access
- 1 May 2024
- Published by Taylor & Francis in HIV/AIDS - Research and Palliative Care
- Vol. ume 16, 203-215
Effect of Dolutegravir-Based First-Line Antiretroviral Therapy on Mother-to-Child Transmission of HIV Among HIV-Exposed Infants in Ethiopia: a Before-and-After Study
Background: Currently, Dolutegravir (DTG)-based regimens are administered to women on Option B plus to prevent mother-to-child transmission (MTCT) of the virus. However, its effect on reducing MTCT of human immunodeficiency virus (HIV) among HIV-exposed infants over the previously used Efavirenz (EFV)-based regimen is unknown. Objective: This study aimed to compare the effects of DTG-based and EFV-based regimens on the MTCT of HIV among HIV-exposed infants in Ethiopia. Methods: An uncontrolled before-and-after study design was conducted among 958 mother-infant pairs (479 on EFV-based and 479 on DTG-based regimens) enrolled in the prevention of mother-to-child transmission (PMTCT) care from September 2015 to February 2023. The outcome variable was the HIV infection status among the exposed infants. A log-binomial model was employed, and the proportion was computed to compare the incidence of MTCT of HIV in both groups. The risk ratio (RR) with a 95% confidence interval (CI) was calculated to assess the predictor variables. Results: Mothers on DTG-based regimens were approximately 44% (adjusted risk ratio (aRR): 0.56; 95% CI: 0.44, 0.70) less likely to transmit HIV to their infants than those on EFV-based regimens. In addition, poor or fair adherence to antiretroviral therapy (ART) (aRR: 5.82; 95% CI: 3.41, 9.93), home delivery (aRR: 3.61; 95% CI: 2.32, 5.62), mixed feeding practice (aRR: 1.83; 95% CI: 1.45, 2.3) and not receiving antiretroviral prophylaxis (aRR: 3.26; 95% CI: 1.6, 6.64) were found to increase the risk of MTCT of HIV infection, whereas older maternal age (aRR: 0.93; 95% CI: 0.9, 0.96) was a protective factor. Conclusion: Mother-to-child transmission of HIV was less frequently observed in mother-infant pairs exposed to the DTG-based regimens as compared to those exposed to the EFV-based regimens. Thus, DTG-based first-line ART regimens supplementation should be sustained to achieve global and national targets for zero new infections in HIV-exposed infants.
- 1 May 2024
- Published by Taylor & Francis in HIV/AIDS - Research and Palliative Care
- Vol. ume 16, 203-215
Open AccessEffect of Dolutegravir-Based First-Line Antiretroviral Therapy on Mother-to-Child Transmission of HIV Among HIV-Exposed Infants in Ethiopia: a Before-and-After Study
Background: Currently, Dolutegravir (DTG)-based regimens are administered to women on Option B plus to prevent mother-to-child transmission (MTCT) of the virus. However, its effect on reducing MTCT of human immunodeficiency virus (HIV) among HIV-exposed infants over the previously used Efavirenz (EFV)-based regimen is unknown. Objective: This study aimed to compare the effects of DTG-based and EFV-based regimens on the MTCT of HIV among HIV-exposed infants in Ethiopia. Methods: An uncontrolled before-and-after study design was conducted among 958 mother-infant pairs (479 on EFV-based and 479 on DTG-based regimens) enrolled in the prevention of mother-to-child transmission (PMTCT) care from September 2015 to February 2023. The outcome variable was the HIV infection status among the exposed infants. A log-binomial model was employed, and the proportion was computed to compare the incidence of MTCT of HIV in both groups. The risk ratio (RR) with a 95% confidence interval (CI) was calculated to assess the predictor variables. Results: Mothers on DTG-based regimens were approximately 44% (adjusted risk ratio (aRR): 0.56; 95% CI: 0.44, 0.70) less likely to transmit HIV to their infants than those on EFV-based regimens. In addition, poor or fair adherence to antiretroviral therapy (ART) (aRR: 5.82; 95% CI: 3.41, 9.93), home delivery (aRR: 3.61; 95% CI: 2.32, 5.62), mixed feeding practice (aRR: 1.83; 95% CI: 1.45, 2.3) and not receiving antiretroviral prophylaxis (aRR: 3.26; 95% CI: 1.6, 6.64) were found to increase the risk of MTCT of HIV infection, whereas older maternal age (aRR: 0.93; 95% CI: 0.9, 0.96) was a protective factor. Conclusion: Mother-to-child transmission of HIV was less frequently observed in mother-infant pairs exposed to the DTG-based regimens as compared to those exposed to the EFV-based regimens. Thus, DTG-based first-line ART regimens supplementation should be sustained to achieve global and national targets for zero new infections in HIV-exposed infants.
- Open Access
- 3 January 2024
- Published by MDPI AG in Preprints.org
Effect of Dolutegravir-Based First-Line Antiretroviral Therapy on Mother-to-Child Transmission of HIV among HIV-Exposed Infants in Southern Ethiopia: A Retrospective Before-After Study
Background: Currently, a Dolutegravir (DTG)-based regimen is administered to women on option B plus to prevent mother-to-child transmission (MTCT) of the virus. However, its effect on reducing MTCT of human immunodeficiency virus (HIV) among exposed infants over the previously used Efavirenz (EFV)-based regimen is unknown. Objective: This study aimed to compare the effects of DTG-based and EFV-based regimens on the MTCT of HIV among exposed infants in southern Ethiopia. Methods: A retrospective before-after study design was employed from March to May 2023 among 958 mother-infant pairs (479 on EFV-based and 479 on DTG-based regimens) enrolled in the prevent mother-to-child transmission (PMTCT) care from September 2015 to February 2023. The outcome variable was the HIV infection status among the exposed infants. A log-binomial model was employed and the proportion was computed to compare the incidence of MTCT of HIV in both groups. The risk ratio (RR) with 95% confidence interval (CI) was calculated to assess the predictor variables. Results: Mothers on a DTG-based regimen were approximately 44% (adjusted risk ratio (aRR): 0.56; 95% CI: 0.44, 0.70) less likely to transmit HIV to their infants than those on an EFV-based regimen. In addition, poor/fair adherence to antiretroviral therapy (ART) (aRR: 5.82; 95% CI: 3.41, 9.93), home delivery (aRR: 3.61; 95% CI: 2.32, 5.62), mixed feeding practice (aRR: 1.83; 95% CI: 1.45, 2.3), and not receiving antiretroviral prophylaxis (aRR: 3.26; 95% CI: 1.6, 6.64) were found to increase the risk of MTCT of HIV infection, whereas older maternal age (aRR: 0.93; 95% CI: 0.9, 0.96) was a protective factor.Conclusion: The Dolutegravir-based regimen significantly reduced MTCT of HIV among exposed infants compared to the EFV-based regimen. Thus, DTG-based first-line ART regimen supplementation should be sustained to achieve global and national targets for zero new infections in HIV-exposed infants.
- 3 January 2024
- Published by MDPI AG in Preprints.org
Open AccessEffect of Dolutegravir-Based First-Line Antiretroviral Therapy on Mother-to-Child Transmission of HIV among HIV-Exposed Infants in Southern Ethiopia: A Retrospective Before-After Study
Background: Currently, a Dolutegravir (DTG)-based regimen is administered to women on option B plus to prevent mother-to-child transmission (MTCT) of the virus. However, its effect on reducing MTCT of human immunodeficiency virus (HIV) among exposed infants over the previously used Efavirenz (EFV)-based regimen is unknown. Objective: This study aimed to compare the effects of DTG-based and EFV-based regimens on the MTCT of HIV among exposed infants in southern Ethiopia. Methods: A retrospective before-after study design was employed from March to May 2023 among 958 mother-infant pairs (479 on EFV-based and 479 on DTG-based regimens) enrolled in the prevent mother-to-child transmission (PMTCT) care from September 2015 to February 2023. The outcome variable was the HIV infection status among the exposed infants. A log-binomial model was employed and the proportion was computed to compare the incidence of MTCT of HIV in both groups. The risk ratio (RR) with 95% confidence interval (CI) was calculated to assess the predictor variables. Results: Mothers on a DTG-based regimen were approximately 44% (adjusted risk ratio (aRR): 0.56; 95% CI: 0.44, 0.70) less likely to transmit HIV to their infants than those on an EFV-based regimen. In addition, poor/fair adherence to antiretroviral therapy (ART) (aRR: 5.82; 95% CI: 3.41, 9.93), home delivery (aRR: 3.61; 95% CI: 2.32, 5.62), mixed feeding practice (aRR: 1.83; 95% CI: 1.45, 2.3), and not receiving antiretroviral prophylaxis (aRR: 3.26; 95% CI: 1.6, 6.64) were found to increase the risk of MTCT of HIV infection, whereas older maternal age (aRR: 0.93; 95% CI: 0.9, 0.96) was a protective factor.Conclusion: The Dolutegravir-based regimen significantly reduced MTCT of HIV among exposed infants compared to the EFV-based regimen. Thus, DTG-based first-line ART regimen supplementation should be sustained to achieve global and national targets for zero new infections in HIV-exposed infants.
- Open Access
- 1 January 2023
- Published by Taylor & Francis in Journal of Multidisciplinary Healthcare
- Vol. ume 16, 75-84
Vaccine Cold Chain Management and Associated Factors in Public Health Facilities and District Health Offices of Wolaita Zone, Ethiopia
Background: Vaccines are medical products with a short shelf life and are easily damaged by deviations in temperature from the recommended ranges. Vaccines lose their quality if the cold chain system is not properly managed. Cold chain management is still a major challenge in developing countries, including Ethiopia. Thus, this study aimed to assess vaccine cold chain management and associated factors at public health facilities and district health offices. Methods: A facility-based cross-sectional study design was applied from March 1– 28, 2021. One hundred and thirty-six health institutions were selected by simple random sampling method. Data was collected using the observation check list and interviewer-administered pre-tested structured questionnaires. Data was analyzed using SPSS version 25. The binary logistic regression was employed and those variables with a p-value less than 0.25 in the bivariate analysis were used for multivariable logistic regression. Then multivariate analysis at a p-value < 0.05 and AOR with 95% CI was used to measure the degree of association between independent variables and the outcome variable. Results: The study indicates that 83 (61%) public health facilities had good cold chain management practice at 95% CI (52.2– 68.4). Experience greater than 2 years (AOR=2.8, 95% CI=1.13– 6.74), good knowledge on cold chain management (AOR=3.02, 95% CI=1.2– 7.4), training on cold chain management (AOR=1.86, 95% CI=1.36– 9.84), and supportive supervision on cold chain management (AOR=2.71, 95% CI=1.1– 7.14) were statistically significantly associated with good cold chain management practice. Conclusion: The result of the study indicated that there was low cold chain management practice in the study area. Strengthening the knowledge of healthcare workers and supportive supervision on cold chain management by giving training and monitoring their practice toward cold chain management may help to improve the cold chain management practice.
- 1 January 2023
- Published by Taylor & Francis in Journal of Multidisciplinary Healthcare
- Vol. ume 16, 75-84
Open AccessVaccine Cold Chain Management and Associated Factors in Public Health Facilities and District Health Offices of Wolaita Zone, Ethiopia
Background: Vaccines are medical products with a short shelf life and are easily damaged by deviations in temperature from the recommended ranges. Vaccines lose their quality if the cold chain system is not properly managed. Cold chain management is still a major challenge in developing countries, including Ethiopia. Thus, this study aimed to assess vaccine cold chain management and associated factors at public health facilities and district health offices. Methods: A facility-based cross-sectional study design was applied from March 1– 28, 2021. One hundred and thirty-six health institutions were selected by simple random sampling method. Data was collected using the observation check list and interviewer-administered pre-tested structured questionnaires. Data was analyzed using SPSS version 25. The binary logistic regression was employed and those variables with a p-value less than 0.25 in the bivariate analysis were used for multivariable logistic regression. Then multivariate analysis at a p-value < 0.05 and AOR with 95% CI was used to measure the degree of association between independent variables and the outcome variable. Results: The study indicates that 83 (61%) public health facilities had good cold chain management practice at 95% CI (52.2– 68.4). Experience greater than 2 years (AOR=2.8, 95% CI=1.13– 6.74), good knowledge on cold chain management (AOR=3.02, 95% CI=1.2– 7.4), training on cold chain management (AOR=1.86, 95% CI=1.36– 9.84), and supportive supervision on cold chain management (AOR=2.71, 95% CI=1.1– 7.14) were statistically significantly associated with good cold chain management practice. Conclusion: The result of the study indicated that there was low cold chain management practice in the study area. Strengthening the knowledge of healthcare workers and supportive supervision on cold chain management by giving training and monitoring their practice toward cold chain management may help to improve the cold chain management practice.
- Open Access
- 1 January 2021
- Published by Taylor & Francis in HIV/AIDS - Research and Palliative Care
- Vol. ume 13, 53-59
HIV/AIDS-Related Training Coverage Sponsored by Centers for Disease Control and Prevention and Associated Factors at Health Facilities Providing Antiretroviral Therapy in Southern Ethiopia
Background: Large numbers of people living with HIV do not know their HIV status and are not on antiretroviral therapy (ART). In this regard, various gap filling in-service trainings were given for health professionals to achieve the global three ninety-five target by 2020. The objective of this study was to assess Centers for Disease Control and Prevention (CDC) sponsored training coverage and related factors at health facilities providing antiretroviral therapy in southern Ethiopia. Methods: A facility-based cross-sectional study was conducted in 27 facilities (15 hospitals and 12 health centers) in five zones of southern Ethiopia who were providing ART services in October 2019. A total of 403 health professionals from the 27 facilities were included in the study. Quantitative data were collected, edited, coded, and entered into EpiData version 3.1 and transported to SPSS 20 statistical software for analysis. Descriptive statistics were conducted and data were summarized using tables. Results: From a total of 403 eligible study participants, 396 were included in the study with the response rate of 98.2%. Our study revealed that only 105 (33.5%) took training to conduct HIV testing for patients who were living with the virus. Our study also showed that all 91 health professionals working in HIV care and the treatment unit took pieces of training related to the service. However, only 102 (45.7%) laboratory professionals had training related to sample collection, HIV testing service, and viral load monitoring. Shortages of supply and equipment, space and trained human resources were claimed by 82 (62.6%), 68 (51.9%), and 46 (35.1%) of respondents, respectively. Conclusion: Our study showed that there was low coverage of trained staff to deliver HIV testing service and viral load monitoring. However, the coverage was good at HIV/AIDS care, treatment, and prevention units. Almost all health facilities have at least one trained staff member working at each service delivery point.
- 1 January 2021
- Published by Taylor & Francis in HIV/AIDS - Research and Palliative Care
- Vol. ume 13, 53-59
Open AccessHIV/AIDS-Related Training Coverage Sponsored by Centers for Disease Control and Prevention and Associated Factors at Health Facilities Providing Antiretroviral Therapy in Southern Ethiopia
Background: Large numbers of people living with HIV do not know their HIV status and are not on antiretroviral therapy (ART). In this regard, various gap filling in-service trainings were given for health professionals to achieve the global three ninety-five target by 2020. The objective of this study was to assess Centers for Disease Control and Prevention (CDC) sponsored training coverage and related factors at health facilities providing antiretroviral therapy in southern Ethiopia. Methods: A facility-based cross-sectional study was conducted in 27 facilities (15 hospitals and 12 health centers) in five zones of southern Ethiopia who were providing ART services in October 2019. A total of 403 health professionals from the 27 facilities were included in the study. Quantitative data were collected, edited, coded, and entered into EpiData version 3.1 and transported to SPSS 20 statistical software for analysis. Descriptive statistics were conducted and data were summarized using tables. Results: From a total of 403 eligible study participants, 396 were included in the study with the response rate of 98.2%. Our study revealed that only 105 (33.5%) took training to conduct HIV testing for patients who were living with the virus. Our study also showed that all 91 health professionals working in HIV care and the treatment unit took pieces of training related to the service. However, only 102 (45.7%) laboratory professionals had training related to sample collection, HIV testing service, and viral load monitoring. Shortages of supply and equipment, space and trained human resources were claimed by 82 (62.6%), 68 (51.9%), and 46 (35.1%) of respondents, respectively. Conclusion: Our study showed that there was low coverage of trained staff to deliver HIV testing service and viral load monitoring. However, the coverage was good at HIV/AIDS care, treatment, and prevention units. Almost all health facilities have at least one trained staff member working at each service delivery point.
- Open Access
- 1 November 2020
- Published by Taylor & Francis in HIV/AIDS - Research and Palliative Care
- Vol. ume 12, 707-715
Depression and Associated Factors Among Adult HIV/AIDS Patients Attending Antiretroviral Therapy at Wolaita Sodo University Teaching and Referral Hospital, Southern Ethiopia
Background: Nearly, 350 million people in the world are currently living with depression. Depression happening in PLHIV leads to alteration of economic productivity, decrease of working abilities, social isolation, physical decline and difficulties in solving problems. This study investigates the burden of depression and associated factors on HIV/AIDS patients attending an ART clinic. Methods: An institution-based cross-sectional study was implemented from April 1 to May 30, 2019 on a total of 417 HIV-positive patients. Systematic random sampling technique was used to access the study participants. Interviewer-administered structured questionnaire was used for data collection. Data were entered in to EpiData 3.1 and then were exported into Statistical Package for the Social Sciences (SPSS window version 20) for analysis. Results: Four hundred ten (410) respondents participated in the study with a response rate of 98.3%. The burden of depression was 50.5% in this study. Male (AOR=1.53; 95%CI: 1.016– 2.311), people living in urban (AOR=2.20; 95%CI: 1.29– 3.75), patients who had opportunistic infection (AOR=1.98; 95%CI: 1.27– 3.11), poor medication adherence (AOR=1.79; 95%CI: 1.13– 2.85) and high HIV-related perceived stigma (AOR=1.66; 95%CI: 1.04– 2.67) were more likely depressed compared to their counterparts. Conclusion: In this study, male sex, those patients living in urban areas, having opportunistic infections, poor medication adherence, and high HIV-related perceived stigma were significantly associated with depression. Hence, organizations working on HIV programs should address these factors to prevent and manage depression among HIV-positive patients.
- 1 November 2020
- Published by Taylor & Francis in HIV/AIDS - Research and Palliative Care
- Vol. ume 12, 707-715
Open AccessDepression and Associated Factors Among Adult HIV/AIDS Patients Attending Antiretroviral Therapy at Wolaita Sodo University Teaching and Referral Hospital, Southern Ethiopia
Background: Nearly, 350 million people in the world are currently living with depression. Depression happening in PLHIV leads to alteration of economic productivity, decrease of working abilities, social isolation, physical decline and difficulties in solving problems. This study investigates the burden of depression and associated factors on HIV/AIDS patients attending an ART clinic. Methods: An institution-based cross-sectional study was implemented from April 1 to May 30, 2019 on a total of 417 HIV-positive patients. Systematic random sampling technique was used to access the study participants. Interviewer-administered structured questionnaire was used for data collection. Data were entered in to EpiData 3.1 and then were exported into Statistical Package for the Social Sciences (SPSS window version 20) for analysis. Results: Four hundred ten (410) respondents participated in the study with a response rate of 98.3%. The burden of depression was 50.5% in this study. Male (AOR=1.53; 95%CI: 1.016– 2.311), people living in urban (AOR=2.20; 95%CI: 1.29– 3.75), patients who had opportunistic infection (AOR=1.98; 95%CI: 1.27– 3.11), poor medication adherence (AOR=1.79; 95%CI: 1.13– 2.85) and high HIV-related perceived stigma (AOR=1.66; 95%CI: 1.04– 2.67) were more likely depressed compared to their counterparts. Conclusion: In this study, male sex, those patients living in urban areas, having opportunistic infections, poor medication adherence, and high HIV-related perceived stigma were significantly associated with depression. Hence, organizations working on HIV programs should address these factors to prevent and manage depression among HIV-positive patients.
- Open Access
- 13 June 2019
- Published by Springer Nature in BMC Health Services Research
- Vol. 19  (1) , 1-6
Compliance with standard precaution practices and associated factors among health care workers in Dawuro Zone, South West Ethiopia, cross sectional study
Infection in healthcare facilities is a major public health problem in most developing countries like Ethiopia. Currently the overall incidence of health care associated infection has been increased and burden of these infections is staggering. This study aimed to assess health care workers compliance with standard precaution practices and associated factors in public health institutions of Dawuro zone, south west Ethiopia, 2016. An institution based cross sectional study was conducted from February1–30/ 2016 in 17 health institutions found in Dawuro zone. Data were collected using a pre-tested questionnaire on 250 health care workers selected by simple random sampling technique. Collected data was checked, coded and analyzed by using SPSS version 20. A P-value less than 0.05 was considered as statistically significant. Two hundred fifty health care workers were participated in the study. Out of the total respondents, 162(65.0%) of respondents had complied with standard precaution practices. Service year less than or equal to 5 years, training on standard precaution, having good hand hygiene and availability of personal protective equipment were independently associated with compliance to standard precaution practices. Significant numbers of health care workers were not complied with standard precaution practices in this study. Therefore strategies targeted in fulfilling health institutions with supplies like hand hygiene material, Personal Protective equipment and training on standard precaution will improve compliance with standard precaution practice.
- 13 June 2019
- Published by Springer Nature in BMC Health Services Research
- Vol. 19  (1) , 1-6
Open AccessCompliance with standard precaution practices and associated factors among health care workers in Dawuro Zone, South West Ethiopia, cross sectional study
Infection in healthcare facilities is a major public health problem in most developing countries like Ethiopia. Currently the overall incidence of health care associated infection has been increased and burden of these infections is staggering. This study aimed to assess health care workers compliance with standard precaution practices and associated factors in public health institutions of Dawuro zone, south west Ethiopia, 2016. An institution based cross sectional study was conducted from February1–30/ 2016 in 17 health institutions found in Dawuro zone. Data were collected using a pre-tested questionnaire on 250 health care workers selected by simple random sampling technique. Collected data was checked, coded and analyzed by using SPSS version 20. A P-value less than 0.05 was considered as statistically significant. Two hundred fifty health care workers were participated in the study. Out of the total respondents, 162(65.0%) of respondents had complied with standard precaution practices. Service year less than or equal to 5 years, training on standard precaution, having good hand hygiene and availability of personal protective equipment were independently associated with compliance to standard precaution practices. Significant numbers of health care workers were not complied with standard precaution practices in this study. Therefore strategies targeted in fulfilling health institutions with supplies like hand hygiene material, Personal Protective equipment and training on standard precaution will improve compliance with standard precaution practice.